Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

CRISPR/Cas9-mediated knockout of Rag-2 causes systemic lymphopenia with hypoplastic lymphoid organs in FVB mice.

Kim JI, Park JS, Kim H, Ryu SK, Kwak J, Kwon E, Yun JW, Nam KT, Lee HW, Kang BC.

Lab Anim Res. 2018 Dec;34(4):166-175. doi: 10.5625/lar.2018.34.4.166. Epub 2018 Dec 31.

2.

Recombination activating gene-2null severe combined immunodeficient pigs and mice engraft human induced pluripotent stem cells differently.

Choi YJ, Kim E, Reza AMMT, Hong K, Song H, Park C, Cho SK, Lee K, Prather RS, Kim JH.

Oncotarget. 2017 Sep 2;8(41):69398-69407. doi: 10.18632/oncotarget.20626. eCollection 2017 Sep 19.

3.
4.

Generation of recombination activating gene-1-deficient neonatal piglets: a model of T and B cell deficient severe combined immune deficiency.

Ito T, Sendai Y, Yamazaki S, Seki-Soma M, Hirose K, Watanabe M, Fukawa K, Nakauchi H.

PLoS One. 2014 Dec 1;9(12):e113833. doi: 10.1371/journal.pone.0113833. eCollection 2014.

5.

Role of the gut-associated and secondary lymphoid tissue in the induction of chronic colitis.

Takebayashi K, Koboziev I, Ostanin DV, Gray L, Karlsson F, Robinson-Jackson SA, Kosloski-Davidson M, Dooley AB, Zhang S, Grisham MB.

Inflamm Bowel Dis. 2011 Jan;17(1):268-78. doi: 10.1002/ibd.21447. Epub 2010 Sep 1.

6.

The immunophenotypic and immunogenotypic B-cell differentiation arrest in bone marrow of RAG-deficient SCID patients corresponds to residual recombination activities of mutated RAG proteins.

Noordzij JG, de Bruin-Versteeg S, Verkaik NS, Vossen JM, de Groot R, Bernatowska E, Langerak AW, van Gent DC, van Dongen JJ.

Blood. 2002 Sep 15;100(6):2145-52.

7.

Differences between immunodeficient mice generated by classical gene targeting and CRISPR/Cas9-mediated gene knockout.

Lee JH, Park JH, Nam TW, Seo SM, Kim JY, Lee HK, Han JH, Park SY, Choi YK, Lee HW.

Transgenic Res. 2018 Jun;27(3):241-251. doi: 10.1007/s11248-018-0069-y. Epub 2018 Mar 28.

8.

RAG-1-deficient mice have no mature B and T lymphocytes.

Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE.

Cell. 1992 Mar 6;68(5):869-77.

PMID:
1547488
10.

V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations.

Villa A, Sobacchi C, Notarangelo LD, Bozzi F, Abinun M, Abrahamsen TG, Arkwright PD, Baniyash M, Brooks EG, Conley ME, Cortes P, Duse M, Fasth A, Filipovich AM, Infante AJ, Jones A, Mazzolari E, Muller SM, Pasic S, Rechavi G, Sacco MG, Santagata S, Schroeder ML, Seger R, Strina D, Ugazio A, Väliaho J, Vihinen M, Vogler LB, Ochs H, Vezzoni P, Friedrich W, Schwarz K.

Blood. 2001 Jan 1;97(1):81-8.

11.
12.

Cellular and molecular analysis of lymphoid development using Rag-deficient mice.

Spanopoulou E.

Int Rev Immunol. 1996;13(4):257-88. Review.

PMID:
8884425
13.

Maturation of B cell precursors is impaired in thymic-deprived nude and old mice.

Szabo P, Zhao K, Kirman I, Le Maoult J, Dyall R, Cruikshank W, Weksler ME.

J Immunol. 1998 Sep 1;161(5):2248-53.

14.

NOD/LtSz-Rag1null mice: an immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells.

Shultz LD, Lang PA, Christianson SW, Gott B, Lyons B, Umeda S, Leiter E, Hesselton R, Wagar EJ, Leif JH, Kollet O, Lapidot T, Greiner DL.

J Immunol. 2000 Mar 1;164(5):2496-507.

15.

Gene therapy of RAG-2-/- mice: sustained correction of the immunodeficiency.

Yates F, Malassis-Séris M, Stockholm D, Bouneaud C, Larousserie F, Noguiez-Hellin P, Danos O, Kohn DB, Fischer A, de Villartay JP, Cavazzana-Calvo M.

Blood. 2002 Dec 1;100(12):3942-9. Epub 2002 Aug 22.

16.
17.

Expression of recombination-activating gene in mature peripheral T cells in Peyer's patch.

Kondo E, Wakao H, Koseki H, Takemori T, Kojo S, Harada M, Takahashi M, Sakata S, Shimizu C, Ito T, Nakayama T, Taniguchi M.

Int Immunol. 2003 Mar;15(3):393-402.

PMID:
12618483
18.

Effects of Microtus fortis lymphocytes on Schistosoma japonicum in a bone marrow transplantation model.

Hu Y, Xu Y, Lu W, Quan H, Shen Y, Yuan Z, Zhang J, Zang W, He Y, Cao J.

Exp Parasitol. 2014 Jul;142:27-37. doi: 10.1016/j.exppara.2014.04.005. Epub 2014 Apr 16.

PMID:
24746640
19.

CRISPR/Cas9-mediated knockout of CD47 causes hemolytic anemia with splenomegaly in C57BL/6 mice.

Kim JI, Park JS, Kwak J, Lim HJ, Ryu SK, Kwon E, Han KM, Nam KT, Lee HW, Kang BC.

Lab Anim Res. 2018 Dec;34(4):302-310. doi: 10.5625/lar.2018.34.4.302. Epub 2018 Dec 31.

20.

Correction of murine Rag1 deficiency by self-inactivating lentiviral vector-mediated gene transfer.

Pike-Overzet K, Rodijk M, Ng YY, Baert MR, Lagresle-Peyrou C, Schambach A, Zhang F, Hoeben RC, Hacein-Bey-Abina S, Lankester AC, Bredius RG, Driessen GJ, Thrasher AJ, Baum C, Cavazzana-Calvo M, van Dongen JJ, Staal FJ.

Leukemia. 2011 Sep;25(9):1471-83. doi: 10.1038/leu.2011.106. Epub 2011 May 27.

PMID:
21617701

Supplemental Content

Support Center